Bookmark and Share

Compound Summary for: CID 170361     Try the new version summary page


Also known as: 249296-44-4; 7,8,9,10-tetrahydro-6h-6,10-methanoazepino[4,5-g]quinoxaline; Varenicline (INN); AC1Q4W6H; CHEMBL1396; NCGC00247735-01
Molecular Formula: C13H13N3   Molecular Weight: 211.26242   InChIKey: JQSHBVHOMNKWFT-UHFFFAOYSA-N
Varenicline is a prescription medication used to treat smoking addiction. This medication is the first approved nicotinic receptor partial agonist. Specifically, varenicline is a partial agonist of the alpha4/beta2 subtype of the nicotinic acetylcholine receptor. In addition it acts on alpha3/beta4 and weakly on alpha3beta2 and alpha6-containing receptors. A full agonism was displayed on alpha7-receptors.   From: DrugBank
Show subcontent titlesTable of Contents
Related Records
show first sub-section only
Use and Manufacturing
Biomedical Effects and Toxicity
Safety and Handling
Environmental Fate and Exposure Potential
Exposure Standards and Regulations
Biomolecular Interactions and Pathways
Biological Test Results
Chemical and Physical Properties
_ _